Cargando…

Treating COVID-19 with colchicine in community healthcare setting

Detalles Bibliográficos
Autores principales:	Della-Torre, Emanuel, Della-Torre, Fabrizio, Kusanovic, Marija, Scotti, Raffaella, Ramirez, Giuseppe Alvise, Dagna, Lorenzo, Tresoldi, Moreno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261351/ https://www.ncbi.nlm.nih.gov/pubmed/32492478 http://dx.doi.org/10.1016/j.clim.2020.108490

Ejemplares similares

Serum IgG4 elevation in hyper-inflamed COVID-19 patients. Author's reply
por: Della-Torre, Emanuel, et al.
Publicado: (2022)

Serum IgG4 level predicts COVID-19 related mortality
por: Della-Torre, Emanuel, et al.
Publicado: (2021)

Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19
por: Ramirez, Giuseppe A., et al.
Publicado: (2021)

Mavrilimumab for severe COVID-19 – Authors' reply
por: De Luca, Giacomo, et al.
Publicado: (2020)

IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19
por: Della-Torre, Emanuel, et al.
Publicado: (2021)

Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic
por: Cavalli, Giulio, et al.
Publicado: (2020)

Basal Serum Diamine Oxidase Levels as a Biomarker of Histamine Intolerance: A Retrospective Cohort Study
por: Cucca, Valentina, et al.
Publicado: (2022)

Cardiac Safety of mRNA-based Vaccines in Patients with Systemic Lupus Erythematosus and Lupus-like Disorders with a History of Myocarditis
por: Ramirez, Giuseppe A., et al.
Publicado: (2022)

Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
por: Cavalli, Giulio, et al.
Publicado: (2020)

Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one year
por: Ramirez, Giuseppe A., et al.
Publicado: (2021)

COVID-19 in systemic lupus erythematosus: Data from a survey on 417 patients
por: Ramirez, Giuseppe A., et al.
Publicado: (2020)

Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse
por: Lanzillotta, Marco, et al.
Publicado: (2018)

Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation
por: Bonaventura, Aldo, et al.
Publicado: (2022)

Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation
por: Della-Torre, Emanuel, et al.
Publicado: (2021)

Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study
por: Campochiaro, Corrado, et al.
Publicado: (2020)

Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients
por: Pignatti, Patrizia, et al.
Publicado: (2023)

A systematic review of the infectious complications of colchicine and the use of colchicine to treat infections
por: McEwan, Timothy, et al.
Publicado: (2021)

Eosinophilic Cellulitis Successfully Treated with Colchicine
por: Ozturk, Murat, et al.
Publicado: (2019)

Wells' Syndrome Successfully Treated with Colchicine
por: Puzas, Álvaro Iglesias, et al.
Publicado: (2017)

Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement()
por: Natalello, Gerlando, et al.
Publicado: (2021)

Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim–Chester Disease
por: Tomelleri, Alessandro, et al.
Publicado: (2018)

B-Lymphocytes in the Pathophysiology of Pancreatic Adenocarcinoma
por: Minici, Claudia, et al.
Publicado: (2022)

Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study
por: Della-Torre, Emanuel, et al.
Publicado: (2020)

Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study
por: Cavalli, Giulio, et al.
Publicado: (2021)

Phagolysosome formation in normal and colchicine-treated macrophages
Publicado: (1975)

Colchicine
por: Ben-Chetrit, Eldad
Publicado: (2018)

Are atopy and eosinophilic bronchial inflammation associated with relapsing forms of chronic rhinosinusitis with nasal polyps?
por: Yacoub, Mona-Rita, et al.
Publicado: (2015)

Myocarditis: An Interleukin-1-Mediated Disease?
por: De Luca, Giacomo, et al.
Publicado: (2018)

Colchicine plus Dapsone in Colchicine‐Resistant FMF Patients
por: Salehzadeh, Farhad, et al.
Publicado: (2019)

Poisoning by Colchicin
Publicado: (1890)

Colchicine and the heart
por: Imazio, Massimo, et al.
Publicado: (2021)

IEEE International Magnetics Conference
por: Della Torre, Edward
Publicado: (1993)

Magnetic hysteresis
por: Della Torre, Edward
Publicado: (1999)

Magnetic Hysteresis
por: Della Torre, Edward
Publicado: (2000)

Non-alcoholic Fatty Liver Disease as a Canonical Example of Metabolic Inflammatory-Based Liver Disease Showing a Sex-Specific Prevalence: Relevance of Estrogen Signaling
por: Della Torre, Sara
Publicado: (2020)

Beyond the X Factor: Relevance of Sex Hormones in NAFLD Pathophysiology
por: Della Torre, Sara
Publicado: (2021)

Diet and Fertility Status: Relevance in Health and Disease
por: Della Torre, Sara
Publicado: (2023)

The Myth of Colchicine in Treating Myopericarditis: Case Report and Literature Review
por: Al-Zakhari, Rana, et al.
Publicado: (2020)

A case of Dressler’s syndrome successfully treated with colchicine and acetaminophen
por: Nomoto, Fumika, et al.
Publicado: (2020)

Is colchicine the holy grail for treating inflammation and reducing cardiovascular risk?
por: Filipiak, Krzysztof J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u2228t2fpo4sts3ucovr8qn8ea